“…Most previous studies, however, failed to show the benefit of SUV to differentiate benign from malignant PETomas. 3,9,10 Although maximum SUV is sometimes clinically useful in differentiating some malignancies, it is subject to variability because of the patient's body composition, period of uptake, lesion size, partial volume averaging and plasma glucose. 11 Also, many PETomas are subcentimetre, and thus maximum SUV may not be accurately calculated.…”